Rossi E D, Martini M, Straccia P, Bizzarro T, Fadda G, Larocca L M
Division of Anatomic Pathology and Histology, Università Cattolica del Sacro Cuore, 'Agostino Gemelli' School of Medicine, Rome, Italy.
Cytopathology. 2016 Feb;27(1):50-8. doi: 10.1111/cyt.12229. Epub 2014 Dec 28.
Our aim was to evaluate the feasibility and diagnostic accuracy of liquid-based cytology (LBC) on lymph node fine needle aspiration (FNA). FNA may fulfil a challenging role in the evaluation of the majority of primary (benign and malignant) diagnoses as well as metastatic lymph node lesions. Although the morphological features may be quite easily recognized, cytological samples with a scant cellular component may raise some issues.
We appraised 263 cytological lymph nodes from different body regions analysed between January and December 2013, including 137 male and 126 female patients, and processed with LBC.
The cytological diagnoses included 160 benign and 103 malignant lesions. We reported 35 benign and 73 malignant lesions from 108 with surgical follow-up. The latter malignant series included 68 metastatic lesions, four suspicious for malignancy and one inadequate sample. The cytological diagnoses were supported by 62 conclusive immunocytochemical and 28 molecular analyses. Of the 108 cases, we documented 35 true negatives, 72 true positives, one false negative and no false positives, resulting in 98.6% sensitivity, 100% specificity, 99% diagnostic accuracy, 97.2% negative predictive value and 100% positive predictive value.
FNA represents the first diagnostic tool in lymph node management and a reliable approach in order to avoid an excision biopsy. Furthermore, LBC is a feasible method for ancillary tests for which methanol-fixed samples are suitable, such as immunocytochemistry and molecular analysis.
我们的目的是评估液基细胞学(LBC)在淋巴结细针穿刺抽吸(FNA)中的可行性和诊断准确性。FNA在大多数原发性(良性和恶性)诊断以及转移性淋巴结病变的评估中可能发挥具有挑战性的作用。尽管形态学特征可能很容易识别,但细胞成分稀少的细胞学样本可能会引发一些问题。
我们评估了2013年1月至12月间分析的来自不同身体部位的263个淋巴结细胞学样本,包括137例男性和126例女性患者,并采用LBC进行处理。
细胞学诊断包括160例良性病变和103例恶性病变。我们报告了108例接受手术随访的病例中的35例良性病变和73例恶性病变。后者的恶性病例系列包括68例转移病变、4例疑似恶性病变和1例样本不足。62例确定性免疫细胞化学分析和28例分子分析支持了细胞学诊断。在这108例病例中,我们记录了35例假阴性、72例假阳性、1例假阴性且无假阳性,灵敏度为98.6%,特异度为100%,诊断准确性为99%,阴性预测值为97.2%,阳性预测值为100%。
FNA是淋巴结管理中的首要诊断工具,也是避免切除活检的可靠方法。此外,LBC是一种可行的辅助检测方法,适用于甲醇固定样本的检测,如免疫细胞化学和分子分析。